Parkinson's Disease Market Development and Research by Acorda Therapeutics, Inc, Amneal Pharmaceuticals LLC , Imugene Limited, Immutep, F. Hoffmann-La Roche Ltd, Osmotica Pharmaceuticals plc

This Parkinson's Disease Market analysis report also offers a list of the chief competitors and provides the strategic insights and analysis of the key factors influencing the industry. All statistical and numerical data is interpreted with the use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis. This Parkinson's Disease Market business document is built with the careful efforts of an innovative, enthusiastic, knowledgeable, and experienced team of analysts, researchers, industry experts, and forecasters. This Parkinson's Disease Market business document provides fact-based and penetrating insights from the customers. Moreover, a clear understanding of the products, services and business model is obtained while forming this Parkinson's Disease Market business document.

Global Parkinson’s Disease Market is rising gradually to an estimated value of USD 9.7 Billion by 2026 registering a healthy CAGR of 12.2% in the forecast period of 2019-2026. This significant rise in market value can increase research development initiatives to launching novel therapies.

Request for Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-parkinsons-disease-market

Key Players are:

Teva Pharmaceutical Industries Ltd,
GlaxoSmithKline Plc,
Acorda Therapeutics, Inc,
Amneal Pharmaceuticals LLC ,
Imugene Limited,
Immutep,
F. Hoffmann-La Roche Ltd,
Osmotica Pharmaceuticals plc, Vertical Pharmaceuticals, LLC,
Adamas Pharmaceuticals, Inc,
Novartis AG,
Eli Lilly and Company,
AbbVie Inc,
few among others.

Parkinson's Disease Market Definition:

Parkinson’s disease is chronic and progressive neurodegenerative disorders that affects dopamine producing neurons in central nervous system. Parkinson’s disease tends to develops in brain over many years. The patient with Parkinson’s disease experience tremor, slow movement, rigid muscle, impaired posture and balance, loss of automatic movements, slurry speech and others.

According to the Clinical Practice Research Data link summary report 2018, it is identified that there were 145,519 prevalence cases of patient with age 20 and above with Parkinson’s disease in UK seen in the year 2018. The estimation incidence cases were 18,461 in patient aged above 45 or over. This significant rise in patient number acts as a driver for the growth of Parkinson’s disease Market.

Parkinson's Disease Market Drivers

Increase in prevalence rate of parkinson’s disease worldwide

Exposure to certain toxin or change in environment may increase the parkinson’s disease

The launch of new products and research collaboration are the prime strategies to reinforce the market position

Growing in aging population as it affect most commonly in geriatric population

Increase in the rate of R&D initiatives is driving parkinson’s disease drug therapeutics market

Parkinson's Disease Market Restraints

High cost involved in the treatment
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market

Lack of awareness among the patient and physician about parkinson’s disease treatment

View Detailed Table of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-parkinsons-disease-market

Segmentation: Global Parkinson’s Disease Market

Parkinson's Disease Market: By Type

Drug-induced parkinsonism
Vascular parkinsonism
Normal pressure hydrocephalus (NSA)
Corticobasal degeneration (CBD)
Progressive supranuclear palsy (PSP)
Multiple system atrophy (MSA)
Idiopathic Parkinson’s
Others

Parkinson's Disease Market: By Mechanism of Cation type

Dopamine agonists
Monoamine oxidase B (MAO-B) inhibitors
Catechol-O-methyltransferase (COMT) inhibitors
Adenosine A2 receptor antagonist

Parkinson's Disease Market: By Drug Type

Amantadine
Safinamide
Brivaracetam
Pimavanserin
Carbidopa and levodopa
Rivastigmine tartrate
Rotigotine
Ferampanel
Apomorphine hydrochloride
Pramipexole
Others

Parkinson's Disease Market: By Therapy

Medication
Deep brain stimulation
Others

Parkinson's Disease Market: By Route of administration

Oral
Parenteral
Sublingual
Others

Parkinson's Disease Market: By End Users

Hospitals
Homecare
Specialty Clinics
Others

Parkinson's Disease Market: By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Parkinson's Disease Market:

In February 2018, Osmotica Pharmaceuticals plc received FDA approval for Osmolex ER (amantadine hydrochloride) which is an extended release tablet indicated for the treatment of parkinson’s disease and drug-induced extrapyramidal reactions in adult patients

In August 2017, Adamas Pharmaceuticals, Inc. received FDA approval Gocovri (amantadine) extended release tablet for the treatment of dyskinesia in patients with parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications

Competitive Analysis: Global Parkinson’s Disease Market

Global parkinson’s disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of parkinson’s disease market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global parkinson’s disease market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

View Full Report @ https://www.databridgemarketresearch.com/reports/global-parkinsons-disease-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others. We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others.

This release was published on openPR.